Swedish protons

Acta Oncologica

Volumn 44, Issue 8, 2005, Pages 793-797

  Goitein, Michael ^a   Goitein, Gudrun ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEAM THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; EDITORIAL; GERIATRIC PATIENT; HEAD AND NECK CARCINOMA; HUMAN; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DEPTH DOSE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; X RAY DOSE DISTRIBUTION;

HUMANS; NEOPLASMS; PROTONS; RADIATION ONCOLOGY; RADIOTHERAPY, CONFORMAL; SWEDEN;

EID: 28844436412     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860500402207     Document Type: Editorial

References (13)

1. Lomax AJ, Bortfeld T, Goitein G, Debus J, Dykstra C, Tercierr PA, et al. A treatment planning inter-comparison of protons and intensity-modulated photon therapy. Radiother Oncol 1999;51:257-71.
2. Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T, Blomquist E, Johansson B, et al. Number of patients potentially eligible for proton therapy. Acta Oncol 2005;44:835-48.
3. Goitein M, Jermann M. The relative costs of proton and x-ray radiation therapy. Clin Oncol (R Coll Radiol) 2003;15:S37-50.
4. Hellman S, Hellman DS. Of mice but not men. Problems of the randomized clinical trial. N Engl J Med 1991;324:1585-9.
5. Fu KK, Pajak TF, Marcial VA, et al. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of the RTOG 83-03. Int J Radiat Oncol Biol Phys 1995;32:577-88.
6. Fyles A, Keane TJ, Barton M, et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-9.
7. Egger E, Schalenbourg A, Zografos L, Bercher L, Boehringer T, Chamot L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 2001;51:138-47.
8. Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 2002;120:1665-71.
9. Bush DA, Slater JD, Bonnet R, Cheek GA, Dunbar RD, Moyers M, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999;116:1313-9.
10. Tsujii H, Mizoe JE, Kamada T, Baba M, Kato S, Kato H, et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 2004;73(Suppl 2):S41-9.
11. Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 2002;120:1665-71.
12. Björk-Eriksson T, Ask A, Glimelius B. The potential of proton beam radiation for palliation and reirradiation. Acta Oncol 2005;44:917-19.
13. Blomquist E, Bjelkengren G, Glimelius B. The potential of proton beam radiation therapy in intracranial and ocular tumours. Acta Oncol 2005;44:861-69.